Stock Events

Stock Events

KNOW LABS INC 

$3.55
46
+$0+0% Friday 20:00

Statistics

Day High
0.09
Day Low
0.07
52W High
35.56
52W Low
0.07
Volume
286,241
Avg. Volume
58,834
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

20MayExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q3 2024
Q4 2024
Q1 2025
-2.4
-1.6
-0.8
0
Expected EPS
-2.4
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-16.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KNWN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap187.56B
Amgen Inc. competes directly in the biotechnology sector focusing on innovative therapeutics, similar to US Biotec.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences operates in the same biopharmaceutical field, developing treatments that overlap with US Biotec's product lines.
Biogen
BIIB
Mkt Cap26.03B
Biogen Inc. focuses on neurological diseases and advanced biologics, competing in the same specialty areas as US Biotec.
Vertex Pharmaceuticals
VRTX
Mkt Cap111.43B
Vertex Pharmaceuticals is involved in creating targeted therapies for serious diseases, a direct competitor in innovation-driven biotech.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals is known for its integrated biopharmaceutical development, similar to US Biotec's approach.
Illumina
ILMN
Mkt Cap19.48B
Illumina Inc. provides genomics solutions, competing with US Biotec in the biotech sector's push towards personalized medicine.
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.29B
Alnylam Pharmaceuticals works on RNAi therapeutics, competing in the innovative drug development space with US Biotec.
Incyte
INCY
Mkt Cap19.09B
Incyte Corporation offers novel therapeutics, directly competing with US Biotec in the field of biopharmaceuticals.
Exelixis
EXEL
Mkt Cap11.76B
Exelixis, Inc. focuses on cancer treatments, competing in the oncology segment where US Biotec is also active.

About

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Show more...
CEO
Mr. Ronald P. Erickson J.D.
Employees
7
Country
US

Listings

XASE
US
USBC
BOATS
BOATS
USBC.BOATS

0 Comments

Share your thoughts

FAQ

What is KNOW LABS INC stock price today?▼
The current price of KNWN is $3.55 USD — it has increased by +0% in the past 24 hours. Watch KNOW LABS INC stock price performance more closely on the chart.
What is KNOW LABS INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange KNOW LABS INC stocks are traded under the ticker KNWN.
What is KNOW LABS INC revenue for the last year?▼
KNOW LABS INC revenue for the last year amounts to 0 USD.
What is KNOW LABS INC net income for the last year?▼
KNWN net income for the last year is -16.9M USD.
How many employees does KNOW LABS INC have?▼
As of April 11, 2026, the company has 7 employees.
In which sector is KNOW LABS INC located?▼
KNOW LABS INC operates in the Information Technology sector.
When did KNOW LABS INC complete a stock split?▼
The last stock split for KNOW LABS INC was on February 19, 2025 with a ratio of 1:40.
Where is KNOW LABS INC headquartered?▼
KNOW LABS INC is headquartered in Seattle, US.